Adaptive Biotechnologies(ADPT) - 2024 Q3 - Quarterly Results

EXHIBIT 99.1 Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results SEATTLE, Nov. 07, 2024 (GLOBE NEWSWIRE) – Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended September 30, 2024. "Our focus on execution and disciplined capital allocation are drivin ...